Bloomberg
@business
The first word in business news | Watch Live: | Newsletters: | Podcasts:
Joined April 2009
104 Following 10.5M Followers
UniQure said that the benefits of its Huntington’s disease gene therapy drug AMT-130 were not as good after four years as they were after three years in a small trial
